{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T17:53:34Z","timestamp":1788630814804,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"am","delay-in-days":291,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R44GM122196"],"award-info":[{"award-number":["R44GM122196"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R44ES031038"],"award-info":[{"award-number":["R44ES031038"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002674","name":"Russian Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["24-15-00066"],"award-info":[{"award-number":["24-15-00066"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ejmech.2024.116768","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T22:33:29Z","timestamp":1723761209000},"page":"116768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Indole-core inhibitors of influenza a neuraminidase: iterative medicinal chemistry and molecular modeling"],"prefix":"10.1016","volume":"277","author":[{"given":"Andrey","family":"Tsedilin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Schmidtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Monakhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Leneva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Falynskova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Khrenova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Ekins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8746-2694","authenticated-orcid":false,"given":"Vadim","family":"Makarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116768_bib1","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1002\/jmv.26990","article-title":"A brief review of influenza virus infection","volume":"93","author":"Javanian","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ejmech.2024.116768_bib2","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1126\/science.323.5921.1560","article-title":"Pandemic influenza: an inconvenient mutation","volume":"323","author":"Layne","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2024.116768_bib3","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3389\/fimmu.2018.01581","article-title":"Influenza A virus cell entry, replication, virion assembly and movement","volume":"9","author":"Dou","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2024.116768_bib4","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1039\/D0RA07283D","article-title":"Recent progress in chemical approaches for the development of novel neuraminidase inhibitors","volume":"11","author":"Mahal","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2024.116768_bib5","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1080\/14656566.2019.1626824","article-title":"Neuraminidase inhibitors as a strategy for influenza treatment: pros, cons and future perspectives","volume":"20","author":"Bassetti","year":"2019","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ejmech.2024.116768_bib7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2334-11-134","article-title":"Systematic review of influenza resistance to the neuraminidase inhibitors","volume":"11","author":"Thorlund","year":"2011","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116768_bib8","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/QCO.0000000000000498","article-title":"Neuraminidase inhibitor resistance in influenza: a clinical perspective","volume":"31","author":"Lee","year":"2018","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116768_bib9","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/cid\/ciz911","article-title":"Resistance of influenza virus to antiviral medications","volume":"71","author":"Whitley","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116768_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature05114","article-title":"The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design","volume":"443","author":"Russell","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116768_bib11","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ncomms1390","article-title":"Mechanism of 150-cavity formation in influenza neuraminidase","volume":"2","author":"Amaro","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2024.116768_bib13","doi-asserted-by":"crossref","first-page":"10493","DOI":"10.1128\/JVI.00959-08","article-title":"Structural characterization of the 1918 influenza virus H1N1 neuraminidase","volume":"82","author":"Xu","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2024.116768_bib14","doi-asserted-by":"crossref","first-page":"7764","DOI":"10.1021\/ja0723535","article-title":"Remarkable loop flexibility in avian influenza N1 and its implications for antiviral drug design","volume":"129","author":"Amaro","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.116768_bib15","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1021\/ja8085643","article-title":"Characterizing loop dynamics and ligand recognition in human- and avian-type influenza neuraminidases via generalized born molecular dynamics and end-point free energy calculations","volume":"131","author":"Amaro","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.116768_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1750-2659.2011.00304.x","article-title":"Influenza neuraminidase","volume":"6","author":"Air","year":"2012","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.ejmech.2024.116768_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fmicb.2019.00039","article-title":"Influenza virus neuraminidase structure and functions","volume":"10","author":"McAuley","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2024.116768_bib18","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nrd2400","article-title":"The war against influenza: discovery and development of sialidase inhibitors","volume":"6","author":"von Itzstein","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.116768_bib19","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nrd2175","article-title":"Antiviral agents active against influenza A viruses","volume":"5","author":"De Clercq","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.116768_bib20","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/nsmb.1909","article-title":"The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site","volume":"17","author":"Li","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2024.116768_bib21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1747-0285.2007.00614.x","article-title":"Novel druggable hot spots in avian influenza neuraminidase H5N1 revealed by computational solvent mapping of a reduced and representative receptor ensemble","volume":"71","author":"Landon","year":"2008","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2024.116768_bib22","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1021\/jm8001197","article-title":"Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase","volume":"51","author":"Cheng","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116768_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000939","article-title":"Molecular dynamics simulations suggest that electrostatic funnel directs binding of Tamiflu to influenza N1 neuraminidases","volume":"6","author":"Le","year":"2010","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ejmech.2024.116768_bib24","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10822-013-9675-1","article-title":"Discover binding pathways using the sliding binding-box docking approach: application to binding pathways of oseltamivir to avian influenza H5N1 neuraminidase","volume":"27","author":"Tran","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2024.116768_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002249","article-title":"Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition","volume":"7","author":"Vavricka","year":"2011","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116768_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.ejmech.2024.116768_bib27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejmech.2018.01.050","article-title":"Discovery of C-1 modified oseltamivir derivatives as potent influenza neuraminidase inhibitors","volume":"146","author":"Ju","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116768_bib28","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1016\/j.bmcl.2018.09.014","article-title":"Design, synthesis, and evaluation of carboxyl-modified oseltamivir derivatives with improved lipophilicity as neuraminidase inhibitors","volume":"28","author":"Wang","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116768_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111940","article-title":"Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity","volume":"187","author":"Ju","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116768_bib30","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1021\/acsmedchemlett.0c00313","article-title":"Design, synthesis, and biological evaluation of novel acylhydrazone derivatives as potent neuraminidase inhibitors","volume":"11","author":"Li","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116768_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112147","article-title":"Discovery of novel \"Dual-site\" binding oseltamivir derivatives as potent influenza virus neuraminidase inhibitors","volume":"191","author":"Ai","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116768_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105139","article-title":"In quest of small-molecules as potent non-competitive inhibitors against influenza","volume":"114","author":"Malbari","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116768_bib34","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1007\/BF00476977","article-title":"Acetals of lactams and acid amides. 61. Synthesis and transamination of indoxyls and pyrrol-2-in-4-ones","volume":"26","author":"Ryabova","year":"1990","journal-title":"Chem. Heterocycl. Compd."},{"key":"10.1016\/j.ejmech.2024.116768_bib35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF02226519","article-title":"Synthesis and pharmacological activity of derivatives of 3-aminomethylene-1-(2\u2032,6\u2032-dichlorophenyl)oxindole and 2-aminomethyleneindoxyl","volume":"29","author":"Isakovich","year":"1995","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejmech.2024.116768_bib36","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/BF00519142","article-title":"Benzenoid-quinone tautomerism in azomethines and their structural analogs. 34. 3-hydroxy-1-methylindole-2-carbaldehyde imines","volume":"21","author":"Sitkina","year":"1985","journal-title":"Chem. Heterocycl. Compd."},{"key":"10.1016\/j.ejmech.2024.116768_bib37","series-title":"Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET","first-page":"210","article-title":"Chapter 5. Sulfonamide as an essential functional group in drug design","author":"Kalgutkar","year":"2010"},{"key":"10.1016\/j.ejmech.2024.116768_bib38","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1021\/jm5007275","article-title":"Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2","volume":"57","author":"Clark","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116768_bib40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2217\/fvl.14.97","article-title":"Complementary assays helping to overcome challenges for identifying neuraminidase inhibitors","volume":"10","author":"Richter","year":"2015","journal-title":"Future Virol."},{"issue":"13","key":"10.1016\/j.ejmech.2024.116768_bib33","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.bmc.2019.05.024","article-title":"Investigation of flexibility of neuraminidase 150-loop using tamiflu derivatives in influenza A viruses H1N1 and H5N1","volume":"27","author":"Zima","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116768_bib55","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","article-title":"The ChEMBL database in 2017","volume":"45","author":"Gaulton","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2024.116768_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103062","article-title":"Synthesis and biological evaluation of indoloquinoline alkaloid cryptolepine and its bromo-derivative as dual cholinesterase inhibitors","volume":"90","author":"Nuthakki","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116768_bib42","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/0040-4020(80)85053-8","article-title":"Double cyclisation of phenylglycine-o-carboxylic acids \u2013 I: new stable mesoionic oxazolone","volume":"36","author":"Tighineanu","year":"1980","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2024.116768_bib43","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1021\/jo01318a021","article-title":"Aminohaloborane in organic synthesis. 2. Simple synthesis of indoles and 1-acyl-3-indolinones using specific ortho .alpha.-chloroacetylation of anilines","volume":"44","author":"Sugasawa","year":"1979","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2024.116768_bib44","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1021\/ja01607a071","article-title":"7-Azaindole. I. Synthesis and conversion to 7-Azatryptophan and other derivatives","volume":"77","author":"Robinson","year":"1955","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.116768_bib45","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bmc.2013.11.031","article-title":"7,7'-Diazaindirubin \u2013 a small molecule inhibitor of casein kinase 2 in vitro and in cells","volume":"22","author":"Cheng","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116768_bib46","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/S0040-4039(00)73031-0","article-title":"Synthesis and reactivity of 1-substituted-3H-pyrrolo[2,3-b]pyridin-3-one","volume":"35","author":"Desarbre","year":"1994","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2024.116768_bib58","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.antiviral.2009.01.006","article-title":"Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005\/2006","volume":"82","author":"Bauer","year":"2009","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ejmech.2024.116768_bib59","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4155\/fmc.10.292","article-title":"Novel neuraminidase inhibitors: identification, biological evaluation and investigations of the binding mode","volume":"3","author":"Kirchmair","year":"2011","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116768_bib60","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2217\/fvl.14.97","article-title":"Complementary assays helping to overcome challenges for identifying neuraminidase inhibitors","volume":"10","author":"Richter","year":"2015","journal-title":"Future Virol."},{"issue":"10","key":"10.1016\/j.ejmech.2024.116768_bib47","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.3390\/v2102269","article-title":"Neuraminidase inhibitor susceptibility testing in human influenza viruses: a laboratory surveillance perspective","volume":"2","author":"Okomo-Adhiambo","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2024.116768_bib48","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1471-2105-10-168","article-title":"Fpocket: an open source platform for ligand pocket detection","volume":"10","author":"Le Guilloux","year":"2009","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.ejmech.2024.116768_bib49","series-title":"AMBER 10","author":"Case","year":"2008"},{"key":"10.1016\/j.ejmech.2024.116768_bib50","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1021\/ci800166p","article-title":"Lead finder: an approach to improve accuracy of protein-ligand docking, binding energy estimation, and virtual screening","volume":"48","author":"Stroganov","year":"2008","journal-title":"J. Chem. Inf. Model."},{"issue":"9","key":"10.1016\/j.ejmech.2024.116768_bib51","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/jcc.21777","article-title":"Impact of 2'-hydroxyl sampling on the conformational properties of RNA: update of the CHARMM all-atom additive force field for RNA","volume":"32","author":"Denning","year":"2011","journal-title":"J. Comput. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2024.116768_bib52","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1021\/ct300400x","article-title":"Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone \u03c6, \u03c8 and side-chain \u03c7(1) and \u03c7(2) dihedral angles","volume":"8","author":"Best","year":"2012","journal-title":"J Chem Theory Comput"},{"issue":"4","key":"10.1016\/j.ejmech.2024.116768_bib53","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116768_bib54","doi-asserted-by":"crossref","DOI":"10.1063\/5.0014475","article-title":"Scalable molecular dynamics on CPU and GPU architectures with NAMD","volume":"153","author":"Phillips","year":"2020","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2024.116768_bib56","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1021\/acs.molpharmaceut.0c01013","article-title":"Bioactivity comparison across Multiple machine learning algorithms using over 5000 datasets for drug discovery","volume":"18","author":"Lane","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2024.116768_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424006494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424006494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T12:14:28Z","timestamp":1738412068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424006494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":57,"alternative-id":["S0223523424006494"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116768","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indole-core inhibitors of influenza a neuraminidase: iterative medicinal chemistry and molecular modeling","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116768"}}